Français
Contact us
Help
Search
Canada Site
A-Z Index
Consultations
Media Room
It's Your
Health
Home
About Health Canada
Consumer Product Safety
Diseases & Conditions
Drugs & Health Products
Adverse Reaction Information
Advisories, Warnings & Recalls
Biologics, Radio-
pharmaceuticals & Genetic Therapies
Compliance & Enforcement
Controlled Substances & Precursor Chemicals
Drug Products
International Activities
MedEffect
Medical Devices
Medical Use of Marihuana
Natural Health Products
Public Involvement & Consultations
Regulatory Requirements for Advertising
Special Access to Drugs & Health Products
Substances: Problematic Use
Veterinary Drugs
Legislation & Guidelines
Reports & Publications
Emergencies & Disasters
Environmental & Workplace Health
First Nations & Inuit Health
Food & Nutrition
Health Care System
Healthy Living
Science & Research
Government
Health Partners
Need
Larger
Text?
Home
>
Drugs & Health Products
>
Drug Products
>
Applications & Submissions
>
Guidance Documents
>
QT/QTc Interval Prolongation
QT/QTc Interval Prolongation
QT/QTc Interval Prolongation: Guidance for Product Monograph Content
Date: 2006-11-30
Guide for the Analysis and Review of QT/QTc Interval Data
Date: 2006-11-30
Health Canada Question and Answer Document Regarding the ICH S7B and E14 Guidances
Date: 2006-11-30
S7B: The Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals
Date: 2006-04-05
E14: The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs
Date: 2006-04-05
Last Updated: 2006-10-03
Important Notices